Compound design method based on V-ATPase enzyme A subunit, vanillin derivative and application
By designing vanillin derivatives based on the A subunit of V-ATPase enzyme, the problem of existing pesticides to pest resistance is solved, the inhibition of V-ATPase enzyme and insecticidal effects are achieved, and the efficient and environmentally friendly Pesticide solutions.
Patent Information
- Application Number
- CN202410997899.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-24
AI Technical Summary
The increased resistance of existing pesticides to agricultural pests leads to a reduced prevention efficiency, and it is necessary to develop efficient green pesticides with novel target sites and unique mechanisms of action.
Based on the compound design method of V-ATPase enzyme A subunit, vanillin derivatives with V-ATPase enzyme inhibitory activity and insecticidal activity were developed through virtual screening and molecular docking technology to prepare V-ATPase inhibitors and killing Insect agent.
It realizes effective inhibition of V-ATPase enzyme and insecticidal effect, provides new target points and mechanism of action, improves the prevention of pesticides, and has environmentally friendly characteristics.
Smart Images

Figure BDA0004960772540000021 
Figure BDA0004960772540000031 
Figure BDA0004960772540000032
Abstract
Description
Technical Field
[0001] The invention belongs to the fields of drug technology and pesticide technology, and relates to a compound design method based on V-ATPase enzyme A subunit, vanillin derivatives and applications. Background Art
[0002] In recent years, due to the irrational application of many pesticides, the resistance of agricultural pests to existing commercial pesticides has increased significantly, and the control effect has decreased significantly. Therefore, it is particularly important to develop highly efficient green pesticides with novel target sites, unique mechanisms of action, and no cross-resistance with existing pesticides.
[0003] Vacuolar H + -ATPase, also known as vesicular adenosine triphosphatase (V-ATPase), is a large membrane-embedded enzyme complex that uses the rotational motion generated by ATP hydrolysis to pump hydrogen ions across the membrane. V-ATPase is the main proton pump responsible for acidification and maintaining the pH of cellular compartments. V-ATPase is a highly conserved multi-subunit gyrase that is widely distributed in all eukaryotic organisms. It plays an irreplaceable role in physiological processes as a proton pump on and within the membrane system. In reports in the medical field, dysfunction of V-ATPase is associated with a variety of diseases, such as cancer, osteoporosis, male infertility, renal acidosis, etc. (ACS Chem.Biol.2022,17(3),619-628). In the field of pesticides, the botanical insecticide Celastrus may bind to certain sites on the H subunit of V-ATPase, inhibiting the assembly of the whole enzyme, thereby affecting the enzyme activity, and the insect cannot perform normal functions and causes death (Toxins 2016,8(3),79.). Therefore, V-ATPase can serve as a potential new target for fungicides and insecticides. Summary of the invention
[0004] The present invention provides a compound design method based on the A subunit of V-ATPase enzyme, vanillin derivatives and applications. For the first time, the allosteric site of the A subunit of V-ATPase enzyme is used for receptor structure-based drug design, and a lead compound containing a vanillin fragment with V-ATPase enzyme inhibitory activity and insecticidal activity is screened and obtained. On this basis, a method for preparing vanillin derivatives and their applications as V-ATPase enzyme inhibitors and insecticidal agents are further provided. The vanillin derivatives of this patent show good V-ATPase enzyme inhibitory activity, V-ATPase enzyme A subunit binding ability and insecticidal activity.
[0005] To achieve the above object, the technical solution adopted by the present invention includes:
[0006] A compound design method based on V-ATPase enzyme A subunit, which designs compounds based on receptor structure for the allosteric site of V-ATPase enzyme A subunit, comprising the following steps:
[0007] Step 1. Preparation of virtual screening ligands: screening of small molecule compound libraries based on drug-like and pesticide-like rules and 2D-to-3D structural transformation;
[0008] Step 2: Preparation of virtual screening receptors: Use homology modeling to construct the 3D structure of the V-ATPase enzyme A subunit protein, and use molecular dynamics methods to optimize the structure;
[0009] Step 3: Virtual screening based on molecular docking: Targeting the allosteric site of V-ATPase A subunit, using the 3D structure of V-ATPase A subunit protein obtained in step 2, considering the flexibility of the receptor, and using molecular docking for virtual screening;
[0010] Step 4: Activity evaluation of the screening molecules: including V-ATPase inhibitory activity evaluation and insecticidal activity evaluation.
[0011] A compound based on the A subunit of V-ATPase enzyme, wherein the compound is obtained by using the compound design method based on the A subunit of V-ATPase enzyme according to the present invention, and specifically comprises at least one of the following molecular structures;
[0012]
[0013]
[0014] The invention discloses an application of the compound based on the A subunit of V-ATPase enzyme for preparing a V-ATPase inhibitor.
[0015] The invention discloses an application of the compound based on the A subunit of V-ATPase enzyme in preparing insecticides.
[0016] A vanillin derivative, wherein the vanillin derivative is designed and synthesized using the compound AN-465 / 41851572 in the present invention as a lead, and the vanillin derivative has a compound having a structure shown in the following general formula or a pharmaceutically acceptable salt thereof;
[0017]
[0018] Among them, R 1 At least one selected from hydrogen, halogen, cyano, nitro, trifluoromethyl and trifluoromethoxy;
[0019] R 2Selected from N-substituted aminomethyl, N-substituted carbamoyl, O-substituted oxymethyl, O-substituted oxycarbonyl, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted benzyl, methyl substituted by a nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by an oxygen-containing heterocycle containing 2-10 carbon atoms, and methyl substituted by a sulfur-containing heterocycle containing 2-10 carbon atoms;
[0020] The substituents in the aforementioned N-substituted aminomethyl, N-substituted carbamoyl, O-substituted oxymethyl, O-substituted oxycarbonyl, and substituted benzyl are each independently selected from at least one of hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, and sulfur-containing heterocycle containing 2-10 carbon atoms;
[0021] R 3 At least one selected from hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, a nitrogen-containing heterocycle containing 2-10 carbon atoms, an oxygen-containing heterocycle containing 2-10 carbon atoms and a sulfur-containing heterocycle containing 2-10 carbon atoms.
[0022] Optionally, the R 1 for chlorine;
[0023] R 2 At least one selected from N-anilinomethyl, N-((4-ethynylphenyl)amino)methyl, N-((4-methoxyphenyl)amino)methyl, N-(isobutylamino)methyl, N-(sec-butylamino)methyl, N-(cyclopentyl)amino)methyl, N-((4-fluorophenyl)amino)methyl, N-((2,4-difluorophenyl)amino)methyl, N-((benzothiazol-2-yl)amino)methyl, 4-(pentylamino)methyl, N,N-((dimethyl)amino)formyl, N-((p-tolyl)amino)formyl, ethoxycarbonyl, butoxycarbonyl, ((but-3-yn-1-yl)oxy)carbonyl, ((2,3,5,6-tetrafluorophenyl)oxy)carbonyl, (o-tolyloxy)carbonyl, cyclohexyloxycarbonyl and ((4-methoxybenzyl)oxy)carbonyl.
[0024] Optionally, it is a compound in the following table;
[0025]
[0026]
[0027]
[0028] Use of any of the vanillin derivatives of the present invention for preparing V-ATPase inhibitors.
[0029] Use of any of the vanillin derivatives of the present invention in preparing insecticides.
[0030] Optionally, the insecticide is used to control at least one of aphids and armyworms.
[0031] The advantages of the present invention are:
[0032] For the first time, a receptor structure-based drug design was conducted for the allosteric site of the A subunit of vacuolar-type H+-ATPases (V-ATPases), and a lead compound containing a vanillin fragment with V-ATPase inhibitory activity and insecticidal activity was screened. On this basis, a method for preparing a vanillin derivative and its application as a V-ATPase inhibitor and insecticidal agent were further provided. The vanillin derivative of the present invention exhibits good V-ATPase inhibitory activity, V-ATPase A subunit binding ability and insecticidal activity. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] The accompanying drawings are used to provide a further understanding of the present disclosure and constitute a part of the specification. Together with the following specific embodiments, they are used to explain the present disclosure but do not constitute a limitation of the present disclosure. In the accompanying drawings:
[0034] Figure 1 V-ATPase inhibitory activity and insecticidal activity of 31 small molecule compounds obtained by virtual screening of the present invention; Note: the inhibitory effect of 200 μM of the compound on V-ATPase and the lethality of 15 mg / mL of the compound on armyworm; BA1, bafilomycin A1 (3 μM); PSP, coumarin P (200 μM against V-ATPase, 1 mg / mL against armyworm). DETAILED DESCRIPTION
[0035] The content of the present invention can be better understood through the following embodiments, but the content of the present invention cannot be limited.
[0036] The allosteric site of the V-ATPase enzyme A subunit of the present invention, taking the oriental armyworm V-ATPase enzyme A subunit protein sequence ((NCBI accession number: KAJ8720449.1)) as an example, is composed of amino acid residues such as Leu43, Arg45, Val52, Lys85, Leu87, Ser88, Glu90, Ile103, Val125, Ser127, Arg171, Tyr202, Ser204, Leu206, Gln207, Val208, Trp209, and Pro210.
[0037] The present invention conducts receptor structure-based drug design for the allosteric site of V-ATPase enzyme A subunit, comprising the following steps:
[0038] Step 1, preparation of virtual screening ligands;
[0039] Step 2, preparation of virtual screening receptors;
[0040] Step 3: Virtual screening based on molecular docking
[0041] Step 4: Activity evaluation of screening molecules
[0042] Furthermore, the key to the step 1, preparation of virtual screening ligands, is to screen the small molecule compound library based on drug-like and pesticide-like rules and perform 2D-to-3D structural transformation.
[0043] The key to the step 2, preparation of virtual screening receptors, is to use homology modeling methods to construct the 3D structure of the A subunit protein of the oriental armyworm V-ATPase enzyme, and use molecular dynamics methods to optimize the structure.
[0044] The key to the virtual screening based on molecular docking in step 3 is to target the allosteric site of the V-ATPase enzyme A subunit, use the -ATPase enzyme A subunit structure obtained in step 2, consider the flexibility of the receptor, and use molecular docking for virtual screening.
[0045] The structures of 31 molecules screened out are as follows:
[0046]
[0047]
[0048] Step 4, activity evaluation of the screening molecules, mainly includes V-ATPase inhibitory activity evaluation and insecticidal activity evaluation.
[0049] The present invention takes the virtually screened compound AN-465 / 41851572 as a lead, including but not limited to using vanillin as a raw material, and preparing vanillin derivatives through three steps of aromatic halogenation reaction, Williamson etherification reaction and imine condensation.
[0050] The vanillin derivative is a compound having a structure shown in the following general formula:
[0051]
[0052] Among them, R 1 At least one selected from hydrogen, halogen, cyano, nitro, trifluoromethyl and trifluoromethoxy;
[0053] R 2 Selected from N-substituted aminomethyl, N-substituted carbamoyl, O-substituted oxymethyl, O-substituted oxycarbonyl, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted benzyl, methyl substituted by a nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by an oxygen-containing heterocycle containing 2-10 carbon atoms, and methyl substituted by a sulfur-containing heterocycle containing 2-10 carbon atoms;
[0054] The substituents in the aforementioned N-substituted aminomethyl, N-substituted carbamoyl, O-substituted oxymethyl, O-substituted oxycarbonyl, and substituted benzyl are independently selected from one or more of hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, and sulfur-containing heterocycle containing 2-10 carbon atoms.
[0055] R 3 One or more selected from hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, sulfur-containing heterocycle containing 2-10 carbon atoms.
[0056] Preferably, R 1 Selected from chlorine;
[0057] R 2Selected from N-anilinomethyl, N-((4-ethynylphenyl)amino)methyl, N-((4-methoxyphenyl)amino)methyl, N-(isobutylamino)methyl, N-(sec-butylamino)methyl, N-(cyclopentyl)amino)methyl, N-((4-fluorophenyl)amino)methyl, N-((2,4-difluorophenyl)amino)methyl, N-((benzothiazol-2-yl)amino)methyl, 4-(pentylamino)methyl, N,N-((dimethyl)amino)formyl, N-((p-tolyl)amino)formyl, ethoxycarbonyl, butoxycarbonyl, ((but-3-yn-1-yl)oxy)carbonyl, ((2,3,5,6-tetrafluorophenyl)oxy)carbonyl, (o-tolyloxy)carbonyl, cyclohexyloxycarbonyl, ((4-methoxybenzyl)oxy)carbonyl
[0058] The compound is one of the compounds shown in the following formula:
[0059] Table 1. Vanillin derivatives shown in general formula
[0060]
[0061]
[0062]
[0063] The compound of the general formula of the present invention has a V-ATPase inhibitory effect and can be used as a V-ATPase inhibitor.
[0064] The compounds of the general formula of the present invention have the activity of killing armyworms and cereal aphids.
[0065] The compound of the general formula of the present invention can be used directly as an insecticide, or can be used with an agriculturally acceptable carrier and other insecticides such as tebufenpyrad, chlorfenapyr, etc. to make a composite insecticide. Some of these compositions show synergistic effects, while others show additive effects.
[0066] Example 1: Drug design based on receptor structure targeting the allosteric site of V-ATPase A subunit
[0067] Receptor structure-based drug design targeting the allosteric site of the A subunit of the V-ATPase enzyme includes the following steps:
[0068] Step 1, preparation of virtual screening ligands;
[0069] Step 2, preparation of virtual screening receptors;
[0070] Step 3: Virtual screening based on molecular docking;
[0071] Step 4: Activity evaluation of the screening molecules;
[0072] Step 1. Preparation of virtual screening ligands, which is crucial for screening the small molecule compound library according to the rules of drug-likeness and pesticide-likeness and the 2D-to-3D structure transformation. The specific method is as follows: The SPECS compound library is based on the rules of drug-likeness (-4 < log P < 4, 0 < MW < 500) and pesticide-likeness (the number of hydrogen bond acceptors (HBA) ≤ 6, the number of hydrogen bond donors (HBD) ≤ 2, the number of rotatable bonds (ROB) ≤ 9); then the Ligand Structure Prepatation method in SYBYLX-2.1 software is used to convert small molecules into 3D structures and the Tripos stance is used to minimize the energy of small molecules.
[0073] Step 2. Preparation of virtual screening receptors, which is crucial for constructing the 3D structure of the A subunit protein of Mythimna separata V-ATPase by homology modeling method and optimizing the structure by molecular dynamics method. The specific method is as follows: Using the crystal structure of the A subunit of bovine V-ATPase (PDB ID: 7KHR) as a template, the sequence of the A subunit protein of Mythimna separata V-ATPase (NCBI accession number: KAJ8720449.1) is constructed into a 3D structure by SWISS-MODEL, denoted as MsVatpA; then the AMBER18 software, AMBER99bsc1 force field and SPC water model are used to model the simulation system; in the simulation system, the target protein is placed at the center of the water box, and the minimum distance from the surface of the water box is To be consistent with the solution environment, insert metal cations and corresponding anions to keep the solution environment neutral; the periodic boundary condition is adopted in the simulation process, and the electrostatic and van der Waals interactions are calculated by PME and Cut-off methods respectively, and the cut-off distances are both All chemical bonds are constrained by the LINCS algorithm; among them, the integration time step is 1 - 3 fs; the specific process is as follows: First, the steepest descent algorithm is used to minimize the energy of the simulation system; then the v-rescale thermostat is used to control the equilibrium temperature of the system, and the berendsen pressure coupling is used to balance the pressure; finally, a molecular dynamics simulation with a time length of not less than 500 ps is carried out on the system in the md integrator; after the kinetic simulation, an average structure is extracted every 500 ps from the last 2500 ps of the equilibrium system, denoted as: MsVatpA-MD1, MsVatpA-MD2, MsVatpA-MD3, MsVatpA-MD4, and MsVatpA-MD5; the energy of the above 5 structures is minimized based on the Tripos stance.
[0074] Step 3: The key to virtual screening based on molecular docking is to target the allosteric site of the V-ATPase enzyme A subunit, use the -ATPase enzyme A subunit structure obtained in step 2, consider the flexibility of the receptor, and use molecular docking for virtual screening. The specific method is as follows: the five structures of V-ATPase enzyme A subunit MsVatpA-MD1, MsVatpA-MD2, MsVatpA-MD3, MsVatpA-MD4, and MsVatpA-MD5 obtained by molecular dynamics optimization in step 2 are used as receptors, the allosteric site of the A subunit is defined as the docking pocket, and the small molecules obtained in step 1 are used as docking screening objects for surfdock docking screening; in surfdock docking, the number of additional starting conformations of each molecule is set to 4, and other parameters are default; then the molecules with a docking score (total score) greater than 8.0 based on each receptor structure are merged; the molecules in the aforementioned union are further docked and screened based on Autodock Vina, using the MsVatpA structure as the receptor and the allosteric site of the A subunit as the docking pocket; in Autodock Vina docking, the size of the docking box is 19.5x 18.0x 18.0A, the exhaustiveness of the global search was set to 20, 12 CPUs were used, the maximum number of binding modes was 20, the maximum energy difference between modes was 4 kcal / mol, and the scoring function weights and terms were set to the default values; molecules with docking scores (binding energies) lower than -6.0 kcal / mol were screened out as a new set of molecules; from the aforementioned set of molecules, 31 molecules were selected based on the principles of large structural variability, low synthesis difficulty, and commercial availability.
[0075] The structures of 31 molecules were selected as follows:
[0076]
[0077]
[0078] Step 4, activity evaluation of the screening molecules, mainly including V-ATPase inhibitory activity evaluation and insecticidal activity evaluation. The evaluation results are shown in Figure 1 .
[0079] Figure 1 The results in the above table firstly show that the 31 compounds screened have obvious V-ATPase inhibitory activity. In particular, compounds AN-465 / 41851572, AG-690 / 12135130, AJ-292 / 14556185 and AG-205 / 12424041 have better V-ATPase inhibitory activity. The IC 50They are 53.04, 99.86, 92.12 and 57.56 μM respectively; secondly, some of the 31 compounds screened have obvious insecticidal activity, especially compound AN-465 / 41851572 has the best insecticidal activity.
[0080] Example 2: Synthesis of Vanillin Derivatives
[0081] The present invention takes the virtually screened compound AN-465 / 41851572 as a lead, including but not limited to using vanillin as a raw material, and preparing vanillin derivatives through three steps of aromatic halogenation reaction, Williamson etherification reaction and imine condensation.
[0082]
[0083] Synthetic routes of vanillin derivatives IA-1-6, IB-1-6, IIB-1-2, and IIC-1-7.
[0084] Synthesis of intermediates:
[0085] Preparation method of intermediate 1: Vanillin (76.1 mg, 0.5 mmol) and NCS (79.8 mg, 0.6 mmol) were dissolved in 2 mL of chloroform, and dimethyl sulfoxide (7 μL, 0.1 mmol) was added at room temperature of 25°C and stirred for 12 h. After the reaction was completed, the mixture was concentrated in vacuo and purified by silica gel column chromatography (ethyl acetate / petroleum ether = 1:1) to obtain intermediate compound 1 (84.6 mg, 91%).
[0086] Preparation method of intermediates 2A and 2B: Compound 1 (1 mmol) or vanillin (1 mmol) was added to a 100 mL dry round-bottom flask, anhydrous potassium carbonate (1.5 mmol) was added, and then dissolved with 20 mL acetonitrile, and then benzyl bromide (1.1 mmol) was added, and the reaction was detected by TLC plate after heating and reflux for 6 hours. After the reaction was completed, the inorganic powder was filtered out, concentrated under reduced pressure, water was added, extracted with dichloromethane, washed with brine, dried over anhydrous sodium sulfate, and then concentrated, and separated by rapid column chromatography to obtain compounds 2A and 2B.
[0087] Table 2. Yield, properties and melting point of intermediates 2A and 2B
[0088] Compound Yield (%) Characteristics Melting point(℃) 2A 87 Yellow solid 75.8-77.6 2B 86 Yellow solid 76.2-78.3
[0089] Synthesis of intermediate 2C: The synthesis method is the same as that of intermediate 2A.
[0090] Synthesis of intermediate 3: In a 500 mL reaction bottle, aldehyde 2B (20.66 mmol), NaH2PO4 (6.20 mmol), H2O2 (35%, 2.3 mL, 21.69 mmol) were added, and 120 mL MeCN / H2O (5:1, v / v) was added and stirred. Then, 30 mL aqueous solution of NaOClO (28.92 mmol) was added dropwise and cooled with water to keep the temperature at 10 °C. The mixture was stirred at room temperature for 90 min, then Na2SO3 (3.2 mmol) was added, and the mixture was stirred for another 5 min to decompose the excess H2O2. The mixture was diluted with aqueous NaCl solution and extracted with ethyl acetate (3×30 mL). The organic extract was separated, washed with aqueous NaCl solution (×2), and extracted with aqueous NaHCO3 solution (×3). The alkaline extract was separated, acidified (concentrated HCl), and extracted with ethyl acetate (×2). The organic extract was dried over Na2SO4 and concentrated to a white solid after crystallization in hexane.
[0091] Synthesis of target compound IA-1-6
[0092] Synthesis of N-(4-(Benzyloxy)-3-methoxybenzyl)aniline (IA-1).
[0093] Compound 2A was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then aniline (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow solid; yield 82%; melting point 83.2-85.1°C; 1 H NMR(400MHz,Chloroform-d)δ7.46(d,J=7.5Hz,2H),7.41-7.35(m,2H),7.35-7.28(m,1H),7.24-7.15(m,2H),6.9 5(s,1H),6.86(s,2H),6.78-6.71(m,1H),6.66(d,J=8.0Hz,2H),5.16(s,2H),4.25(s,2H),3.89(d,J=1.2Hz,3H); 13C NMR(101MHz,Chloroform-d)δ150.00,148.30,147.53,137.35,132.67,129.37,128 .65,127.93,127.38,119.82,117.76,114.30,113.03,111.54,71.27,56.13,48.40.
[0094] Synthesis of N-(4-(Benzyloxy)-3-methoxybenzyl)ethylamine (IA-2)
[0095] Compound 2A was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then 4-ethynylaniline (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow solid; yield 69%; melting point 68.5-70.1°C; 1 H NMR(400MHz,Chloroform-d)δ7.39-7.28(m,5H),6.89-6.83(m,2H),6.80(dd,J=8.2,2.0Hz,1H) ,6.65-6.61(m,2H),6.58(d,J=8.7Hz,2H),5.13(s,2H),4.66(s,1H),4.27(s,2H),3.86(s,3H); 13 C NMR(101MHz,Chloroform-d)δ151.25,150.60,149.98,147.70,137.04,133.82,133.73, 130.93,128.62,127.96,127.35,119.66,114.46,112.45,111.21,71.13,56.07,47.36.
[0096] Synthesis of N-(4-(Benzyloxy)-3-methoxybenzyl)-O-methylhydroxylamine (IA-3).
[0097] Compound 2A was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, then O-methylhydroxylamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow-brown solid; yield 75%; melting point 63.2-65.4°C; 1 H NMR(400MHz,Chloroform-d)δ7.47-7.41(m,2H),7.40-7.34(m,2H),7.34-7.27(m,1H),6.94(d,J=1.4Hz,1H),6 .84(d,J=1.0Hz,2H),6.82-6.76(m,2H),6.66-6.59(m,2H),5.15(s,2H),4.20(s,2H),3.88(s,3H),3.75(s,3H); 13 CNMR(101MHz,Chloroform-d)δ152.30,149.82,147.34,142.46,137.25,132.77,128.58 ,127.85,127.30,119.73,114.91,114.28,114.06,111.41,71.12,56.01,55.83,49.26.
[0098] Synthesis of N-(4-(Benzyloxy)-3-methoxybenzyl)-2-methyl-1-propylamine (IA-4).
[0099] Compound 2A was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, then isobutylamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow liquid; the yield was 77%; 1H NMR(400MHz,Chloroform-d)δ7.47-7.41(m,2H),7.40-7.33(m,2H),7.32-7.27(m,1H),6.95(d,J=1.9Hz,1H),6.86-6.75( m,2H),5.14(s,2H),3.90(s,3H),3.72(s,2H),2.44(d,J=6.8Hz,2H),1.79(hept,J=6.7Hz,1H),0.93(s,3H),0.92(s,3H); 13 CNMR(101MHz,Chloroform-d)δ149.71,147.16,137.37,133.70,128.57,127.8 2,127.32,120.22,113.97,111.94,71.16,57.37,56.03,53.79,28.26,20.77.
[0100] Synthesis of N-(4-(Benzyloxy)-3-methoxybenzyl)butan-2-amine (IA-5).
[0101] Compound 2A was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then sec-butylamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow solid; yield 78%; melting point 68.5-70.0°C; 1 H NMR(400MHz,Chloroform-d)δ7.43(d,J=7.0Hz,2H),7.35(dd,J=8.2,6.5Hz,2H ),7.32-7.27(m,1H),6.92(d,J=1.9Hz,1H),6.85-6.75(m,2H),5.14(s,2H),3.9 0(s,3H),3.80-3.65(m,2H),2.61(dq,J=12.6,6.0Hz,1H),1.60-1.47(m,1H),1 .37(dq,J=13.1,7.2Hz,1H),1.08(dd,J=6.3,1.1Hz,3H),0.90(t,J=7.4Hz,3H); 13C NMR(101MHz,Chloroform-d)δ149.72,147.12,137.36,133.98,128.55,127.81,1 27.31,120.24,114.07,112.04,71.15,56.04,54.00,51.17,29.45,19.74,10.35.
[0102] Synthesis of N-(4-(Benzyloxy)-3-methoxybenzyl)cyclopentylamine (IA-6).
[0103] Compound 2A was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then cyclopentylamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow liquid; the yield was 81%; 1 H NMR(400MHz,Chloroform-d)δ7.46-7.40(m,2H),7.39-7.32(m,2H),7.32-7.27( m,1H),6.91(d,J=1.9Hz,1H),6.85-6.75(m,2H),5.13(s,2H),3.90(s,3H),3.70( s,2H),3.11(p,J=6.8Hz,1H),1.93-1.80(m,2H),1.69(ddq,J=7.4,5.5,2.7Hz,2H ),1.54(dddd,J=11.8,9.9,6.2Hz,2H),1.38(dddd,J=14.1,12.4,6.6,1.8Hz,2H); 13 C NMR(101MHz,Chloroform-d)δ149.68,147.16,137.33,133.61,128.54,127.8 0,127.29,120.36,114.01,112.15,71.13,59.16,56.03,52.47,33.01,24.15.
[0104] Synthesis of target compounds IB-1 to IB-6
[0105] Synthesis of N-(4-(Benzyloxy)-3-chloro-5-methoxybenzyl)aniline (IB-1).
[0106] Compound 2B was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then aniline (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow solid; yield 90%; melting point 75.1-78.5°C; 1 H NMR(400MHz,Chloroform-d)δ7.57-7.52(m,2H),7.42-7.31(m,3H),7.24-7.17(m,2H),7.01(d,J=1.9Hz,1H),6.86 (d,J=2.0Hz,1H),6.76(tt,J=7.3,1.1Hz,1H),6.64(dt,J=7.8,1.1Hz,2H),5.04(s,2H),4.26(s,2H),3.84(s,3H); 13 C NMR(101MHz,Chloroform-d)δ154.27,147.99,143.39,137.30,136.39,129.43,128 .79,128.57,128.43,128.20,120.66,118.03,113.08,110.10,75.00,56.25,48.08;
[0107] Synthesis of N-(4-(Benzyloxy)-3-chloro-5-methoxybenzyl)-4-fluoroaniline (IB-2).
[0108] Compound 2B was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then 4-fluoroaniline (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow-brown solid; yield 85%; melting point 75.1-79.2°C; 1 H NMR(400MHz,Chloroform-d)δ7.58-7.49(m,2H),7.44-7.29(m,3H),6.99(d,J=1.9H z,1H),6.93-6.80(m,3H),6.59-6.50(m,2H),5.03(s,2H),4.22(s,2H),3.84(s,3H); 13CNMR(101MHz,Chloroform-d)δ156.21(d,J=235.5Hz),154.33,144.30,143.48,137.30,136.14,128.86, 128.59,128.45,128.23,120.69,115.87(d,J=22.4Hz),113.94(d,J=7.4Hz),110.10,75.02,56.28,48.69
[0109] Synthesis of N-(4-(Benzyloxy)-3-chloro-5-methoxybenzyl)-2,4-difluoroaniline (IB-3).
[0110] Compound 2B was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then 2,4-difluoroaniline (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow solid; yield 82%; melting point 74.5-75.1°C; 1 H NMR(400MHz,Chloroform-d)δ7.56-7.49(m,2H),7.41-7.29(m,3H),6.99(d,J=1.9Hz,1H),6.89-6.76(m, 2H),6.76-6.68(m,1H),6.54(td,J=9.3,5.4Hz,1H),5.03(s,2H),4.26(s,2H),4.16(s,1H),3.84(s,3H); 13 C NMR(101MHz,Chloroform-d)δ157.07-152.69(m),154.39,150.95(dd,J=241.8,11.5Hz),143.56,137.26,135.68,132.94(d,J=11.6Hz),128.94,1 28.58,128.45,128.24,120.57,112.48(dd,J=8.8,4.4Hz),110.82(dd,J =21.6,3.8Hz),109.88,103.66(dd,J=26.7,22.7Hz),75.02,56.28,48.06
[0111] Synthesis of N-(4-(Benzyloxy)-3-chloro-5-methoxybenzyl)benzothiazol-2-amine (IB-4).
[0112] Compound 2B was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then benzothiazolamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a white solid; yield 80%; melting point 83.3-91.1°C; 1 H NMR(400MHz,Chloroform-d)δ7.60(d,J=7.9Hz,1H),7.57-7.45(m,3H),7.41-7.28(m,4H),7.17-7.07(m ,1H),7.01(d,J=2.0Hz,1H),6.87(d,J=2.1Hz,1H),5.89(s,1H),5.02(s,2H),4.58(s,2H),3.82(s,3H); 13 C NMR(101MHz,Chloroform-d)δ167.13,154.41,152.32,143.97,137.18,134.28,130.68,128.99 ,128.61,128.47,128.28,126.23,122.07,121.12,121.04,119.27,110.42,75.05,56.31,48.89 Synthesis of N-(4-(Benzyloxy)-3-chloro-5-methoxybenzyl)cyclopentylamine (IB-5).
[0113] Compound 2B was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then cyclopentylamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a yellow liquid; the yield was 80%; 1 H NMR(400MHz,Chloroform-d)δ7.54-7.47(m,2H),7.39-7.30(m,3H),6.96(dd,J=10.7,2.0Hz,2H),4.99(s,2H),3.85( s,3H),3.77(s,2H),3.17(p,J=6.9Hz,1H),1.89(qd,J=9.3,7.9,4.2Hz,2H),1.73(t,J=4.2Hz,2H),1.60-1.43(m,4H);13 C NMR(101MHz,Chloroform-d)δ154.20,143.84,137.26,128.62,128.55,128.4 4,128.21,123.31,122.27,111.76,74.96,58.78,56.30,51.25,31.91,24.20
[0114] Synthesis of N-(4-(Benzyloxy)-3-chloro-5-methoxybenzyl)pentan-1-amine (IB-6).
[0115] Compound 2B was added to a 50 mL round-bottom flask, dissolved with 15 mL of dichloromethane, and then pentylamine (1.1 mmol) was added, followed by sodium triacetoxyborohydride (1.4 mmol), stirred for one minute, and then glacial acetic acid (1 mmol) was added, and stirred overnight at room temperature. After the reaction was completed, the reaction was quenched with 5% sodium bicarbonate solution, extracted with dichloromethane, dried with anhydrous sodium sulfate, and separated by rapid column chromatography to obtain a white solid; yield 80%; melting point 51.2-52.6°C; 1 H NMR(400MHz,Chloroform-d)δ7.56-7.48(m,2H),7.35(dt,J=13.7,6.8Hz,3H),6.95(s,1H),6.89(s,1H),5.01(s,2H),3. 86(s,3H),3.74(s,2H),2.63(t,J=7.4Hz,2H),1.55(t,J=7.3Hz,2H),1.32(dq,J=7.3,3.3Hz,4H),0.90(t,J=6.7Hz,3H); 13 CNMR(101MHz,Chloroform-d)δ154.14,143.41,137.31,135.99,128.56,128.49,128. 42,128.18,121.71,111.13,74.96,56.28,53.16,49.12,29.55,29.27,22.66,14.15.
[0116] Example 4. Synthesis of target compounds ⅠIB-1 to ⅠIB-2
[0117] Synthesis of 4-benzyloxy-3-chloro-5-methoxy-N,N-dimethylbenzamide (ⅠⅠB-1).
[0118] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, stirred at room temperature for a few minutes, and then dimethylamine (0.45 mmol) was added. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; difference 75%; melting point 99.6-101.5°C; 1 H NMR (400MHz, Chloroform-d) δ7.54-7.48(m,2H),7.40-7.29(m,3H),7.02(d,J=1. 8Hz,1H),6.92(d,J=1.9Hz,1H),5.05(s,2H),3.87(s,3H),3.04(d,J=31.2Hz,6H); 13 C NMR (101MHz, Chloroform-d) δ170.11,154.16,145.33,136.93,132.55,128.56,128.44,128.31,120.71,110.33,75.05,56.31,39.78,35.60.
[0119] Synthesis of 4-benzyloxy-3-chloro-5-methoxy-N-(p-tolyl)benzamide (ⅠⅠB-2).
[0120] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, stirred at room temperature for a few minutes, and then p-toluidine (0.45 mmol) was added. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 86%; melting point 145.5-150.6°C; 1 HNMR(400MHz,Chloroform-d)δ7.70(s,1H),7.50(td,J=6.8,6.3,1.9Hz,4H),7 .45-7.29(m,5H),7.18(d,J=8.2Hz,2H),5.12(s,2H),3.93(s,3H),2.35(s,3H); 13 C NMR(101MHz,Chloroform-d)δ164.93,154.37,147.11,136.76,135.18,134.66,131.45, 129.78,128.76,128.68,128.53,128.47,120.45,119.98,110.73,75.15,56.44,21.07.
[0121] Synthesis of target compounds ⅠIC-1~ⅠIC-7
[0122] Synthesis of ethyl 4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠIC-1).
[0123] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, stirred at room temperature for a few minutes, and then ethanol (0.45 mmol) was added. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 86%; melting point 57.3-58.2°C; 1 H NMR(400MHz,Chloroform-d)δ7.70(d,J=1.9Hz,1H),7.50(td,J=3.9,3.0,1.6Hz,3H),7. 42-7.29(m,3H),5.12(s,2H),4.37(q,J=7.1Hz,2H),3.92(s,3H),1.39(t,J=7.1Hz,3H); 13 C NMR (101MHz, Chloroform-d) δ165.44,153.76,148.11,136.82,128.69,128.59,128.47,128.39,126.65,123.81,112.02,75.08,61.49,56.37,14.44.
[0124] Synthesis of butyl 4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠIC-2).
[0125] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, and then butanol (0.45 mmol) was added after stirring at room temperature for a few minutes. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 86%; melting point 81.2-83.8°C; 1 H NMR(400MHz,Chloroform-d)δ7.69(d,J=1.8Hz,1H),7.54-7.46(m,3H),7.41-7.29(m,3H),5.12(s,2H ), 4.31 (t, J = 6.7Hz, 2H), 3.92 (s, 3H), 1.80-1.68 (m, 2H), 1.47 (h, J = 7.4Hz, 2H), 0.99 (t, J = 7.4Hz, 3H); 13C NMR(101MHz,Chloroform-d)δ165.52,153.77,148.11,136.82,128.70,128.60,12 8.49,128.40,126.69,123.77,112.05,75.09,65.38,56.37,30.87,19.37,13.89.
[0126] Synthesis of butyl 3-alkyn-1-yl 4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠIC-3).
[0127] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, stirred at room temperature for a few minutes, and then propargyl alcohol (0.45 mmol) was added. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a yellow solid; yield 76%; melting point 78.4-80.5°C; 1 H NMR(400MHz,Chloroform-d)δ7.71(d,J=2.1Hz,1H),7.54-7.47(m,3H),7.42-7.30(m,3H),5.13 (s,2H),4.42(t,J=6.8Hz,2H),3.92(s,3H),2.67(td,J=6.9,2.7Hz,2H),2.05(t,J=2.7Hz,1H); 13 C NMR(101MHz,Chloroform-d)δ165.11,153.77,148.35,136.76,128.75,128.57,1 28.47,128.40,126.02,123.95,112.11,79.95,75.08,70.27,63.01,56.36,19.18 Synthesis of 2,3,5,6-tetrafluorophenyl 4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠⅠC-4).
[0128] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, and 2,3,5,6-phenol (0.45 mmol) was added after stirring at room temperature for a few minutes. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 76%; melting point 131.7-134.3°C; 1H NMR(400MHz,Chloroform-d)δ7.90(d,J=2.0Hz,1H),7.62(d,J=2.0Hz,1H),7.56-7.4 9(m,2H),7.43-7.32(m,3H),7.06(tt,J=10.0,7.0Hz,1H),5.20(s,2H),3.96(s,3H); 13 C NMR (101MHz, Chloroform-d) δ 161.52, 154.06, 149.72, 147.45 (d, J = 4.1Hz), 144.96, 142.08, 139. 58,136.56,129.27,128.63,128.58,125.22,123.00,112.84,103.60(t,J=22.8Hz),75.30,56.52.
[0129] Synthesis of o-tolyl-4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠIC-5).
[0130] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, and then o-methylphenol (0.45 mmol) was added after stirring at room temperature for a few minutes. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 88%; melting point 146.3-152.8°C; 1 H NMR(400MHz,Chloroform-d)δ7.93(d,J=1.9Hz,1H),7.67(d,J=2.0Hz,1H),7.59-7.52(m,2H),7.44-7.34(m,3H),7.30( td,J=7.3,1.9Hz,2H),7.22(td,J=7.4,1.5Hz,1H),7.13(dd,J=7.8,1.4Hz,1H),5.19(s,2H),3.96(s,3H),2.25(s,3H); 13 C NMR(101MHz,Chloroform-d)δ163.70,153.93,149.49,148.79,136.72,131.35,130.34,128.95, 128.60,128.52,128.46,127.16,126.37,125.50,124.46,121.97,112.48,75.17,56.43,16.36.
[0131] Synthesis of cyclohexyl 4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠIC-6).
[0132] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, and cyclohexanol (0.45 mmol) was added after stirring at room temperature for a few minutes. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 76%; melting point 81.8-82.1°C; 1 H NMR(400MHz,Chloroform-d)δ7.70(d,J=1.9Hz,1H),7.51(dt,J=4.2,1.7Hz,3H),7.41-7.30(m,3H),5.12(s,2H),5.00(tt,J=8.7,3. 9Hz,1H),3.92(s,3H),2.03-1.88(m,2H),1.80(ddd,J=14.1,6.5,3.9Hz,2H),1.59(ddt,J=12.5,9.1,4.6Hz,3H),1.54-1.18(m,4H); 13 C NMR(101MHz,Chloroform-d)δ164.76,153.69,147.96,136.79,128.57,128.44,12 8.35,127.15,123.85,123.68,112.02,75.04,73.74,56.32,31.70,25.50,23.81.
[0133] Synthesis of 4-methoxybenzyl 4-benzyloxy-3-chloro-5-methoxybenzoate (ⅠIC-7).
[0134] Compound 3 (0.3 mmol), EDCI (0.45 mmol) and DMAP (0.06 mmol) were added to 20 mL of dichloromethane, and 4-methoxyphenol (0.45 mmol) was added after stirring at room temperature for a few minutes. The reaction was monitored by TLC. After the reaction was completed, the mixture was filtered and loaded into a column, and then chromatographed on a silica gel column and concentrated under reduced pressure to obtain a white solid; yield 78%; melting point 55.4-55.8°C; 1 H NMR (400MHz, Chloroform-d) δ7.70 (dd, J = 2.0, 1.2Hz, 1H), 7.55-7.47 (m, 3H), 7.42-7. 29(m,5H),6.92(d,J=8.7Hz,2H),5.28(s,2H),5.12(s,2H),3.90(s,3H),3.82(s,3H); 13C NMR(101MHz,Chloroform-d)δ165.39,159.91,153.78,148.24,136.79,130.37,128.74,128 .61,128.49,128.42,128.00,126.43,123.95,114.16,112.16,75.10,67.09,56.40,55.44.
[0135] The vanillin derivatives synthesized in the embodiments of the present invention have good crystal form and purity. The melting points of all compounds have been determined and their structures are shown in Table 1. 1 H NMR and 13 C NMR confirmed.
[0136] Example 3, determination of insecticidal activity
[0137] Sticky insect activity test
[0138] The insecticidal activity of the compounds against the third-instar larvae of armyworms was determined by the poison-loaded leaf method. Fresh wheat leaves (5 mm × 5 mm) were immersed in an acetone solution containing the test compound. After the acetone evaporated, the loaded leaves were placed in a 24-well cell plate and used to feed the third-instar larvae that had been starved for 12 hours. Each compound treatment was repeated 3 times, and each cell plate was a replicate, with a total of 72 third-instar armyworm larvae tested. Flubendiamide and periptergin P (PSP) treatments were used as positive controls, and acetone treatment was used as a negative control. Then, the cell plates were wrapped with a wet cloth and placed in a controlled environment at 25°C and 70% relative humidity. The mortality rate was recorded after 48 hours. The median lethal concentration (LC50) was further determined. 50 ) to determine the toxicity of the corresponding compounds.
[0139] Table 3 LC of target compounds against 3rd instar armyworm 50 value
[0140]
[0141] It can be seen from the activity data in Table 3 that the vanillin derivatives exhibit good insecticide activity. In particular, compounds IB-1 and IIB-3 have excellent insecticide activity. 50 0.93 and 0.68 mg / mL respectively.
[0142] Activity test of Cereal Aphid
[0143] The compound to be tested was dissolved in acetone and diluted into Tween water containing 0.1% Tween 80, with a final acetone concentration of 0.1%. Wheat leaves with wingless adult aphids were soaked in the compound solution for 3 seconds, and the droplets remaining on the leaves were blotted with filter paper and then placed in a petri dish containing soaked filter paper. The positive control agent was thiamethoxam, and the negative control was treated with distilled water containing 0.1% Tween 80 and 0.1% acetone. Thirty wingless adult aphids were treated for each treatment, repeated 3 times, and their mortality was determined after 24 hours and 48 hours. The toxicity of the compounds with better activity was further determined, and the LC was calculated using SPSS software. 50 and 95% confidence limits.
[0144] Corrected mortality rate (%) = (mortality rate of treatment group - mortality rate of control group) / (1-mortality rate of control group) × 100%;
[0145] Table 4 LC of target compounds against Rhizopus graminearum 50 value
[0146]
[0147] From the activity data in Table 4, it can be seen that the vanillin derivatives exhibit good aphidicide activity. In particular, compound IB-1 has excellent insecticidal activity, and its LC 50 It is 7.83 mg / L, close to the commercial pesticide thiamethoxam.
[0148] The insecticidal activity showed that some compounds showed good insecticidal activity against armyworm and cereal aphid, among which compounds IB-1 and IB-6 had the best activity. The stomach toxicity LC value of IB-1 against the 3rd instar armyworm larvae was 50 The insecticidal activity was higher than that of the control agent, the natural product PSP (LC 50 =1.57 mg / mL), and the lead compound AN-465 / 41851572 (LC 50 =21.28 mg / mL), the activity was increased by 22.88 times. The LC of IB-1 and IB-6 against wingless adult aphids of Aphis graminearum 50 The aphidicide activity was 7.83 mg / L and 7.92 mg / L, which was about 5.4 times higher than that of PSP (42.53 mg / L) and more than 13 times higher than that of the lead compound 41851572 (104.53 mg / L).
[0149] Example 4. V-ATPase inhibition assay
[0150] The V-ATPase inhibition assay procedure is as follows:
[0151] Buffer preparation
[0152] Ringer Solution: 25mmol / L HEPES, 150mmol / L NaCl, 3.5mmol / L KCl, 1.8mmol / LNa HCO3, 1.0mmol / L MgSO4, 1.7mmol / L CaCl2, 5mmol / L Glucose, pH=7.1.
[0153] Lysis Buffer-PIC: 5mmol / L Na-HEPES, 2mmol / L EGTA, 10mmol / L MercaptoEtOH, Ph=7.1.
[0154] Lysis Buffer+PIC: 5mmol / L Na-HEPES, 2mmol / L EGTA, 10mmol / L MercaptoEtOH, PIC (Protease Inhibitor Cocktail), pH=7.1; PO Buffer: 160mmol / L Tris-Mes, pH=6.9; MV Buffer: 30mmol / L MgCl2, 0.8mmol / L Orthovanadate, boiled at 98℃ for 3min; KN Buffer: 160mmol / L KCl, 4mmol / L NaN3 (10×KN: 2.6mg / mL); 8mmol / L Tris-ATP: prepared with dd H2O to 8mmol / L, stored at -20℃ after aliquoting; Bafilomycin A1: diluted with DMSO to 48μmol / L (positive control agent).
[0155] Sodium molybdate solution: Add 3 parts of 200mmol / L sodium molybdate solution to 6 parts of ddH2O, then add 1 part of freshly prepared 24% sulfuric acid.
[0156] Malachite Green: 18.5 mg of malachite green was dissolved in 25 mL of 1% polyvinyl alcohol.
[0157] Enzyme solution preparation
[0158] Determination of the effect of the target compound on V-ATPase activity: Pick the 6th instar unstarved sticky worm, dissect and take the midgut, discard the contents and peritrophic membrane, remove the Malpighian tubules and food residues in the pre-cooled Ringer Solution, take the posterior part of the midgut, place it in a pre-cooled low-adsorption EP tube, and quickly freeze it in liquid nitrogen and store it at -80℃. When used, add 20μL Lysis buffer-PIC and homogenize it thoroughly on ice with a micro-homogenizer rod. Centrifuge at 20000rpm, 4℃ for 20min; discard the supernatant, add 200μL Lysis buffer-PIC, resuspend the precipitate, and centrifuge at 20000rpm, 4℃ for 20min. After discarding the supernatant, dissolve the precipitate in 1mL Lysis buffer+PIC, and then divide it into 150μL in 1.5mL EP tubes and store it at -20℃ for use.
[0159] Enzyme reaction
[0160] The specific operation method is as follows: Take out the enzyme solution obtained in the above step, add 750μL Lysis buffer + PIC to dilute 6 times. Add 50μL Buffer PO, 20μL MV, 20μL KN to a 1.5mL EP tube, then add 40μL of the above enzyme solution, 10μL DMSO (negative control) or test compound (treatment group) or Bafilomycin A1 (positive control), and each treatment is repeated three times. After incubation at 30℃ for 30min, add 20μL substrate Tris-ATP (8mmol / L) to each centrifuge tube in turn, and incubate at 30℃ for 1h before stopping the reaction. The experiment is set to react at 0 time, which is used as a blank control, that is, after incubation for 1h, add 20μL substrate Tris-ATP (8mmol / L) and stop the reaction immediately.
[0161] Determination of inorganic phosphorus content: (1) Pipette 100 μL of sodium molybdate solution into a 1.5 mL centrifuge tube for later use; (2) Add 50 μL of 20% TCA solution into the sample tube of the enzymatic reaction and react at 70°C for 15 seconds to terminate the reaction; (3) Centrifuge the sample tube at 12,000 rpm for 1 minute; (4) Then take 30 μL of the supernatant, add it to a centrifuge tube containing 100 μL of sodium molybdate solution to dissolve and mix, react for 15 seconds, add 30 μL of malachite green solution and mix; (5) After reacting for 2 minutes, add 200 μL of 7.8% sulfuric acid and mix; (6) After incubating at room temperature for 70 minutes, measure its absorbance at a wavelength of 625 nm.
[0162] Calculation of enzyme activity inhibition rate Inhibition rate of the test compound on V-ATPase % = (ΔODn-ΔODi) / ΔODn×100%. ΔODn = absorbance value of negative control-absorbance value of blank control ΔODi = absorbance value of treatment group-absorbance value of blank control The experiment was repeated three times and the average value was taken.
[0163] V-ATPase inhibition test results:
[0164] Table 5 IC of target compounds against V-ATPase 50
[0165]
[0166]
[0167] The results in Table 5 show that the vanillin derivatives have good V-ATPase inhibitory activity, especially IIC-5 and IIC-6, which have higher V-ATPase inhibitory activity. 50 77.43 and 73.71 μM respectively.
[0168] Among the above target compounds, compounds IB-1 and IB-6, which had higher inhibitory activity against V-ATPase and insecticidal activity against third-instar armyworm larvae, were tested for their binding ability to the A subunit of V-ATPase by isothermal titration calorimetry (ITC).
[0169] Binding ability of compounds to V-ATPase A subunit:
[0170] Table 6 Thermodynamic parameters and dissociation constants of compounds binding to V-ATPase A subunit
[0171] Compound <![CDATA[K d (μM)]]> n ΔH(kJ / mol) ΔS(J / mol·K) 41851572 1.000E-9 0.567 100.00 507.7 IB-1 8.037E-7 0.797 100.00 452.1 IB-6 7.112E-8 0.644 100.00 472.2
[0172] The results are shown in Table 6. Both IB-1 (Kd = 0.8037 μM) and IB-6 (Kd = 0.0711 μM) showed strong binding ability. The binding ability of IB-6 was greater than that of IB-1, which is consistent with the inhibitory activity on V-ATPase. The thermodynamic parameter values of IB-1 and IB-6 showed that the binding of the two compounds to the A subunit of V-ATPase was an entropy-driven process, which may be caused by hydrophobic interactions, which is consistent with the performance of the lead compound 41851572. The protein binding data showed that the compounds still acted on the A subunit of V-ATPase after optimization.
[0173] The above are only a few embodiments of the present application and do not constitute any form of limitation to the present application. Although the present application is disclosed as above with preferred embodiments, it is not intended to limit the present application. Any technician familiar with the profession, without departing from the scope of the technical solution of the present application, using the technical content disclosed above to make slight changes or modifications are equivalent to equivalent implementation cases and fall within the scope of the technical solution.
Claims
1. A compound design method based on V-ATPase enzyme A subunit, characterized in that: The receptor structure-based compound design targeting the allosteric site of the A subunit of the V-ATPase enzyme includes the following steps: Step 1. Preparation of virtual screening ligands: screening of small molecule compound libraries based on drug-like and pesticide-like rules and 2D-to-3D structural transformation; Step 2: Preparation of virtual screening receptors: Use homology modeling to construct the 3D structure of the V-ATPase enzyme A subunit protein, and use molecular dynamics methods to optimize the structure; Step 3: Virtual screening based on molecular docking: Targeting the allosteric site of V-ATPase A subunit, using the 3D structure of V-ATPase A subunit protein obtained in step 2, considering the flexibility of the receptor, and using molecular docking for virtual screening; Step 4: Activity evaluation of the screening molecules: including V-ATPase inhibitory activity evaluation and insecticidal activity evaluation.
2. A compound based on V-ATPase enzyme A subunit, characterized in that, The compound is obtained by the compound design method based on the V-ATPase enzyme A subunit according to claim 1, and specifically includes at least one of the following molecular structures; 3. Use of the compound based on V-ATPase A subunit according to claim 2 for preparing V-ATPase inhibitors.
4. Use of the compound based on V-ATPase enzyme A subunit according to claim 2 for preparing insecticides.
5. A vanillin derivative, characterized in that The vanillin derivative is designed and synthesized using the compound AN-465 / 41851572 in claim 2 as a lead, and the vanillin derivative has a compound having a structure shown in the following general formula or a pharmaceutically acceptable salt thereof; Among them, R 1 At least one selected from hydrogen, halogen, cyano, nitro, trifluoromethyl and trifluoromethoxy; R 2 Selected from N-substituted aminomethyl, N-substituted carbamoyl, O-substituted oxymethyl, O-substituted oxycarbonyl, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted benzyl, methyl substituted by a nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by an oxygen-containing heterocycle containing 2-10 carbon atoms, and methyl substituted by a sulfur-containing heterocycle containing 2-10 carbon atoms; The substituents in the aforementioned N-substituted aminomethyl, N-substituted carbamoyl, O-substituted oxymethyl, O-substituted oxycarbonyl, and substituted benzyl are each independently selected from at least one of hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, and sulfur-containing heterocycle containing 2-10 carbon atoms; R 3 At least one selected from hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, a nitrogen-containing heterocycle containing 2-10 carbon atoms, an oxygen-containing heterocycle containing 2-10 carbon atoms and a sulfur-containing heterocycle containing 2-10 carbon atoms.
6. The vanillin derivative according to claim 5, characterized in that The R 1 for chlorine; R 2 At least one selected from N-anilinomethyl, N-((4-ethynylphenyl)amino)methyl, N-((4-methoxyphenyl)amino)methyl, N-(isobutylamino)methyl, N-(sec-butylamino)methyl, N-(cyclopentyl)amino)methyl, N-((4-fluorophenyl)amino)methyl, N-((2,4-difluorophenyl)amino)methyl, N-((benzothiazol-2-yl)amino)methyl, 4-(pentylamino)methyl, N,N-((dimethyl)amino)formyl, N-((p-tolyl)amino)formyl, ethoxycarbonyl, butoxycarbonyl, ((but-3-yn-1-yl)oxy)carbonyl, ((2,3,5,6-tetrafluorophenyl)oxy)carbonyl, (o-tolyloxy)carbonyl, cyclohexyloxycarbonyl and ((4-methoxybenzyl)oxy)carbonyl.
7. The vanillin derivative according to claim 5 or 6, characterized in that For the compounds in the following table; 8. Use of the vanillin derivative according to any one of claims 5 to 7 for preparing a V-ATPase inhibitor.
9. Use of the vanillin derivative according to any one of claims 5 to 7 for preparing insecticides.
10. The use according to claim 9, characterized in that: The insecticide is used for preventing and controlling at least one of aphids and armyworms.
Citation Information
Patent Citations
3-alkoxybenzamide derivative and pest control agent
CN115052856A
6-quinoline compound or salt thereof, and insecticidal bactericide for agricultural and horticultural use and animal insecticide containing the same
JP2018016601A
N-(4-pyrazolyl) amide derivatives, chemicals for agricultural and horticultural use, and usage of the same
US20040043904A1
Combating pests with benzyl phenyl ethers
US4145439A
